Share on LinkedInShare on LinkedIn

ARTICLE · 03 JUNE 2020

Vaping And COVID-19: Expect A Wave Of Litigation Based On Unsubstantiated Public Concern And Studies With Uncertain Validity

Wilson Elser Moskowitz Edelman & Dicker LLP
Explore more from Wilson Elser Moskowitz Edelman & Dicker LLP

Vaping has been linked to several lung diseases including the one with the indicative name of "e-cigarette, or vaping, product use-associated lung injury" (EVALI)1 .

United StatesCoronavirus (COVID-19)

Vaping has been linked to several lung diseases including the one with the indicative name of "e-cigarette, or vaping, product use-associated lung injury" (EVALI)1 . It is thus not unexpected that during the COVID-19 pandemic, when the virus primarily attacks the lungs, vaping is suspected to be connected with the disease in a number of ways. These suspected connections are as yet not supported by any scientific evidence. Past litigation has taught us that unsubstantiated public concern may nonetheless expose an entire industry to waves of product liability lawsuits and settlement payments in the range of billions of dollars. It is therefore important that producers and companies in the chain of distribution of vaping liquid and devices closely monitor the scientific developments on any possible associations between vaping and COVID-19, and make risk management decisions in anticipation of future lawsuits.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from